Athira Pharma, Inc.

NasdaqCM:ATHA Stock Report

Market Cap: US$17.8m

Athira Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ATHA?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds323,0668.19%
Individual Insiders512,05213%
VC/PE Firms540,29613.7%
Institutions1,048,27826.6%
General Public1,520,19538.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 59.79% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.7%
Perceptive Advisors LLC
540,296US$2.4m0%0.05%
8.19%
BML Capital Management, LLC
323,066US$1.5m0%0.99%
5.03%
Richard Kayne
198,367US$896.6k0%no data
5.01%
Baselake Management, LLC
197,481US$892.6k0%no data
4.09%
Steven Oliveira
161,218US$728.7k-19.2%no data
3.9%
The Vanguard Group, Inc.
153,789US$695.1k0%no data
3.79%
Simplify Asset Management Inc.
149,279US$674.7k0%0.01%
3.79%
Propel Bio Management, LLC
149,279US$674.7k0%0.63%
1.52%
Tang Capital Management, LLC
59,998US$271.2k0%0.01%
1.32%
Renaissance Technologies LLC
51,924US$234.7k115%no data
1.02%
Acadian Asset Management LLC
40,186US$181.6k-0.89%no data
0.98%
Pathstone Family Office, LLC
38,606US$174.5k3.73%no data
0.95%
BlackRock, Inc.
37,643US$170.1k-0.01%no data
0.88%
Mark Litton
34,549US$156.2k31.7%no data
0.86%
Citadel Advisors LLC
33,987US$153.6k61.8%no data
0.82%
Bank of America Corporation
32,524US$147.0k-21.7%no data
0.78%
Geode Capital Management, LLC
30,593US$138.3k-0.01%no data
0.64%
Braden Leonard
25,128US$113.6k0%no data
0.53%
Susquehanna International Group, LLP
20,986US$94.9k161%no data
0.43%
Kevin Church
16,890US$76.3k29.2%no data
0.38%
Two Sigma Advisers, LP
14,860US$67.2k-3.63%no data
0.37%
John Fluke
14,488US$65.5k0%no data
0.28%
Mark Worthington
11,188US$50.6k33.6%no data
0.28%
Robert Renninger
10,919US$49.4k21.7%no data
0.27%
State Street Global Advisors, Inc.
10,737US$48.5k-0.01%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/28 02:58
End of Day Share Price 2025/11/26 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Athira Pharma, Inc. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Esther Lannie HongBerenberg
Jason ButlerCitizens JMP Securities, LLC
Corinne JohnsonGoldman Sachs